Trial Profile
Randomised, Double-blinded, Open Label Study in Pregnant Women, Exploring the Impact of Acellular Pertussis Vaccination in Pregnancy on the Immunogenicity in Infants Randomized to Receive Either an Acellular (aP) or Whole Cell Pertussis (wP) Vaccine Subsequently
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2024
Price :
$35
*
At a glance
- Drugs DTaP poliovirus vaccine (Primary) ; Diphtheria tetanus and pertussis vaccine
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Acronyms GaPs
- 15 Mar 2022 Planned primary completion date changed from 1 Oct 2021 to 18 May 2022.
- 15 Mar 2022 Status changed from recruiting to active, no longer recruiting.
- 08 Mar 2019 Planned primary completion date changed from 1 Dec 2021 to 1 Oct 2021.